miR-218 Involvement in Cardiomyocyte Hypertrophy Is Likely through Targeting REST.
miR-218 Involvement in Cardiomyocyte Hypertrophy Is Likely through Targeting REST.
复制标题
miR-218 可能通过靶向 REST 参与心肌细胞肥大
DOI:
10.3390/ijms17060848
复制
发表时间:
2016-05-31
影响因子:
5.6
通讯作者:
Peng LY
中科院分区:
文献类型:
--
作者:
Liu JJ;Zhao CM;Li ZG;Wang YM;Miao W;Wu XJ;Wang WJ;Liu C;Wang D;Wang K;Li L;Peng LY
MicroRNAs (miRNAs) have been identified as key players in cardiomyocyte hypertrophy, which is associated with significant risks of heart failure. However, many microRNAs are still not recognized for their functions in pathophysiological processes. In this study, we evaluated effects of miR-218 in cardiomyocyte hypertrophy using both in vitro and in vivo models. We found that miR-218 was evidently downregulated in a transverse aortic constriction (TAC) mouse model. Overexpression of miR-218 is sufficient to reduce hypertrophy, whereas the suppression of miR-218 aggravates hypertrophy in primary cardiomyocytes induced by isoprenaline (ISO). In addition, we identified RE1-silencing transcription factor (REST) as a novel target of miR-218; it negatively regulated the expression of REST in hypertrophic cardiomyocytes and the TAC model. These results showed that miR-218 plays a crucial role in cardiomyocyte hypertrophy, likely via targeting REST, suggesting a potential candidate target for interfering hypertrophy.